CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands |
9 Months Ended |
Sep. 30, 2017 |
Sep. 30, 2016 |
| Cash flows from operating activities |
|
|
| Net loss |
$ (5,387)
|
$ (4,955)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Stock-based compensation |
848
|
943
|
| Amortization of deferred debt issuance costs and debt discount |
4
|
740
|
| Amortization of trademark |
98
|
98
|
| Gain on settlement of customer refund |
(68)
|
0
|
| Gain on conversion of debt to common stock |
0
|
(557)
|
| Provision for doubtful accounts |
20
|
153
|
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable |
709
|
(437)
|
| Inventories |
607
|
(1,156)
|
| Prepaid expenses and other |
362
|
(299)
|
| Accounts payable |
356
|
(633)
|
| Accrued expenses |
(212)
|
(124)
|
| Customer refund |
(504)
|
(10)
|
| Due to related parties |
(10)
|
0
|
| Net cash used in operating activities |
(3,177)
|
(6,237)
|
| Cash flows from financing activities |
|
|
| Proceeds from issuance of preferred stock, net |
0
|
2,393
|
| Issuance of common stock, net of issuance cost |
419
|
0
|
| Proceeds from issuance of convertible notes |
1,346
|
0
|
| Debt discount |
(74)
|
0
|
| Short term loan - related party |
100
|
0
|
| Proceeds from the issuance of IPO common stock and warrants |
0
|
8,151
|
| IPO costs |
0
|
(689)
|
| Payments of bridge financing |
0
|
(462)
|
| Proceeds from issuance of bridge financing |
0
|
406
|
| Payments on trademark note payable |
0
|
(450)
|
| Proceeds from credit facility |
107
|
581
|
| Payments on credit facility |
0
|
(785)
|
| Deferred financing costs |
0
|
(57)
|
| Net cash provided by financing activities |
1,898
|
9,088
|
| Net (decrease) increase in cash |
(1,279)
|
2,851
|
| Cash, beginning of the period |
1,453
|
119
|
| Cash, end of the period |
174
|
2,970
|
| Cash paid during the period for: |
|
|
| Interest |
1
|
55
|
| Non-cash investing and financing activities: |
|
|
| Conversion of related party debt into equity |
100
|
0
|
| Warrants issued in connection with notes payable |
44
|
0
|
| Exchange of debt for equity upon IPO |
0
|
3,520
|
| Reclassification of deferred IPO costs |
$ 0
|
$ 619
|